Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyang Su

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
American Journal of Physiology. Cell Physiology|March 19, 2020
The LQT-associated calmodulin mutant E141G induces disturbed Ca<sup>2+</sup>-dependent binding and a flickering gating mode of the Ca<sub>V</sub>1.2 channelJingyang Su, Qinghua Gao, Lifeng Yu, et al.
Frontiers in Pharmacology|May 2, 2024
Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysisJingyang Su, Jialin Zhang, Yuqian Wu, et al.
Expert Review of Anticancer Therapy|July 14, 2022
Efficacy and safety of multi-kinase inhibitors in patients with radioiodine-refractory differentiated thyroid cancer: a systematic review and meta-analysis of clinical trialsJingyang Su, Menglei Wang, Yue Fu, et al.
Cell Calcium|May 20, 2026
Calmodulin inhibitors chlorpromazine and calmidazolium cause calcium overload and oxidative stress despite reducing peak density of Ca<sub>V</sub>1.2 current in ventricular myocytesJingyang Su, Mingjie Hao, Qinghua Gao, et al.
Bioorganic Chemistry|April 25, 2025
A calmodulin-derived peptide TI-16 inhibits Alzheimer's disease progression by decreasing -Aβ burden and restoring calcium dyshomeostasisJingyang Su, Jun Wei, Bowen Zhang, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
American Journal of Physiology. Cell Physiology|March 19, 2020
The LQT-associated calmodulin mutant E141G induces disturbed Ca<sup>2+</sup>-dependent binding and a flickering gating mode of the Ca<sub>V</sub>1.2 channelJingyang Su, Qinghua Gao, Lifeng Yu, et al.
Frontiers in Pharmacology|May 2, 2024
Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysisJingyang Su, Jialin Zhang, Yuqian Wu, et al.
Expert Review of Anticancer Therapy|July 14, 2022
Efficacy and safety of multi-kinase inhibitors in patients with radioiodine-refractory differentiated thyroid cancer: a systematic review and meta-analysis of clinical trialsJingyang Su, Menglei Wang, Yue Fu, et al.
Cell Calcium|May 20, 2026
Calmodulin inhibitors chlorpromazine and calmidazolium cause calcium overload and oxidative stress despite reducing peak density of Ca<sub>V</sub>1.2 current in ventricular myocytesJingyang Su, Mingjie Hao, Qinghua Gao, et al.
Bioorganic Chemistry|April 25, 2025
A calmodulin-derived peptide TI-16 inhibits Alzheimer's disease progression by decreasing -Aβ burden and restoring calcium dyshomeostasisJingyang Su, Jun Wei, Bowen Zhang, et al.
Pageof 4